Synthesis and antitumor and antiviral activities of 1- -D-arabinofuranosylpyrimidine 3',5'-cyclic phosphates.
D000257:Adenoviridae Infections / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D001089:Arabinose; D002234:Carbodiimides; D000242:Cyclic AMP; D003561:Cytarabine / Q000138:chemical synthesis; D003597:Cytosine Nucleotides / Q000138:chemical synthesis / Q000627:therapeutic use; D005128:Eye Diseases / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy; D007668:Kidney / Q000201:enzymology; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009232:Myxoma / Q000188:drug therapy; D009711:Nucleotides / Q000138:chemical synthesis*; D010727:Phosphoric Diester Hydrolases; D011557:Pseudorabies / Q000188:drug therapy; D011742:Pyrimidine Nucleotides / Q000138:chemical synthesis / Q000627:therapeutic use; D011817:Rabbits; D014500:Uracil Nucleotides / Q000138:chemical synthesis / Q000627:therapeutic use; D014615:Vaccinia / Q000188:drug therapy
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D002234:Carbodiimides; D003597:Cytosine Nucleotides; D009711:Nucleotides; D011742:Pyrimidine Nucleotides; D014500:Uracil Nucleotides; D003561:Cytarabine; D001089:Arabinose; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases